Self-efficacy dimensions | N | Time | IHT | Â | CAU | Â | t | DF | p | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | 95% CI | Mean | 95% CI | |||||||||
 |  |  | Lower | Upper | Lower | Upper | ||||||
Optimism | 126 | Baseline | 4.03 | 3.73 | 4.32 | 4.30 | 3.91 | 4.68 | 1.10 | 124 | 0.27 | |
 | 125 | 6 weeks | 4.23 | 3.98 | 4.48 | 4.25 | 3.93 | 4.56 | 0.07 | 123 | 0.94 | |
 | 112 | 26 weeks | 4.12 | 3.83 | 4.38 | 4.23 | 3.84 | 4.62 | 0.50 | 110 | 0.62 | |
Advocacy | 125 | Baseline | 4.61 | 4.35 | 4.87 | 4.43 | 4.07 | 4.78 | −0.86 | 123 | 0.39 | |
 | 125 | 6 weeks | 4.65 | 4.43 | 4.87 | 4.65 | 4.40 | 4.91 | 0.01 | 123 | 0.99 | |
 | 112 | 26 weeks | 4.69 | 4.50 | 4.88 | 4.71 | 4.38 | 5.03 | 0.70 | 110 | 0.94 | |
Coping | 124 | Baseline | 3.67 | 3.39 | 3.95 | 3.78 | 3.36 | 4.20 | 0.44 | 122 | 0.66 | |
 | 125 | 6 weeks | 4.04 | 3.80 | 4.28 | 3.88 | 3.53 | 4.23 | -0.74 | 123 | 0.46 | |
 | 111 | 26 weeks | 3.86 | 3.62 | 4.11 | 4.01 | 3.66 | 4.37 | 0.72 | 109 | 0.47 | |
Self-efficacy | 124 | Baseline | 3.99 | 3.74 | 4.24 | 4.09 | 3.73 | 4.46 | 0.48 | 122 | 0.63 | |
 | 125 | 6 weeks | 4.23 | 4.01 | 4.44 | 4.17 | 3.89 | 4.44 | -0.34 | 123 | 0.74 | |
 | 112 | 26 weeks | 4.11 | 3.90 | 4.33 | 4.20 | 3.85 | 4.54 | 0.44 | 110 | 0.66 |